Cargando…

Human Neutrophil Peptide-1 (HNP-1): A New Anti-Leishmanial Drug Candidate

The toxicity of available drugs for treatment of leishmaniasis, coupled with emerging drug resistance, make it urgent to find new therapies. Antimicrobial peptides (AMPs) have a strong broad-spectrum antimicrobial activity with distinctive modes of action and are considered as promising therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dabirian, Sara, Taslimi, Yasaman, Zahedifard, Farnaz, Gholami, Elham, Doustdari, Fatemeh, Motamedirad, Mahdieh, Khatami, Shohreh, Azadmanesh, Kayhan, Nylen, Susanne, Rafati, Sima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798388/ https://www.ncbi.nlm.nih.gov/pubmed/24147170 http://dx.doi.org/10.1371/journal.pntd.0002491

Ejemplares similares

Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen
por: Zahedifard, Farnaz, et al.
Publicado: (2014)

In Silico Analysis of Six Known Leishmania major Antigens and In Vitro Evaluation of Specific Epitopes Eliciting HLA-A2 Restricted CD8 T Cell Response
por: Seyed, Negar, et al.
Publicado: (2011)

Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice
por: Abdossamadi, Zahra, et al.
Publicado: (2017)

Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy
por: Taslimi, Yasaman, et al.
Publicado: (2016)

Novel strategy using live non-pathogenic Leishmania expressing selected parasite antigens as a candidate vaccine for leishmaniasis
por: Rafati, Sima, et al.
Publicado: (2011)

Visualization of Leishmania tropica Infection in BALB/c Mice by Bioluminescence Imaging
por: Eskandar, Mahdieh, et al.
Publicado: (2020)

Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis
por: Saljoughian, Noushin, et al.
Publicado: (2013)

Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials
por: Zahedifard, Farnaz, et al.
Publicado: (2019)

Correction: Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials
por: Zahedifard, Farnaz, et al.
Publicado: (2019)

Comparison of Protective Potency of DNA and Live Vaccines Expressing A2-CPA-CPB(-CTE) Antigens against Visceral Leishmaniasis in Syrian Hamster as Preliminary Study
por: TASLIMI, Yasaman, et al.
Publicado: (2020)

Antibiotic-Free Nanoplasmids as Promising Alternatives for Conventional DNA Vectors
por: Seyed, Negar, et al.
Publicado: (2022)

C-Terminal Domain Deletion Enhances the Protective Activity of cpa/cpb Loaded Solid Lipid Nanoparticles against Leishmania major in BALB/c Mice
por: Doroud, Delaram, et al.
Publicado: (2011)

Possible Diagnostic Improvement for Cutaneous Leishmaniasis: Is It Achievable?
por: Taslimi, Yasaman, et al.
Publicado: (2018)

Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis
por: Shahbazi, Mehdi, et al.
Publicado: (2015)

Lactoferrin and Human Neutrophil Protein (HNP) 1–3 Levels During the Neonatal Period in Preterm Infants
por: Faust, Kirstin B., et al.
Publicado: (2022)

Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites
por: Badirzadeh, Alireza, et al.
Publicado: (2017)

High Fidelity Processing and Activation of the Human α-Defensin HNP1 Precursor by Neutrophil Elastase and Proteinase 3
por: Tongaonkar, Prasad, et al.
Publicado: (2012)

HNP-1 and HBD-1 as Biomarkers for the Immune Systems of Elite Basketball Athletes
por: Pero, Raffaela, et al.
Publicado: (2020)

Opposing effects of HNP1 (α-defensin-1) on plasma cholesterol and atherogenesis
por: Higazi, Mohamed, et al.
Publicado: (2020)

Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania tropica
por: Masoudzadeh, Nasrin, et al.
Publicado: (2020)

Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study
por: Albrethsen, Jakob, et al.
Publicado: (2005)

Purinergic Enhancement of Anti-Leishmanial Effector Functions of Neutrophil Granulocytes
por: Möller, Sonja, et al.
Publicado: (2021)

Single, Double and Quadruple Alanine Substitutions at Oligomeric Interfaces Identify Hydrophobicity as the Key Determinant of Human Neutrophil Alpha Defensin HNP1 Function
por: Zhao, Le, et al.
Publicado: (2013)

Diagnostic and Therapeutic Potential for HNP-1, HBD-1 and HBD-4 in Pregnant Women with COVID-19
por: Brancaccio, Mariarita, et al.
Publicado: (2022)

Leishmanial Abscess
por: Arora, Sandeep, et al.
Publicado: (2017)

Enhancement of the activity of the antimicrobial peptides HNP1 and LL-37 by bovine pancreatic ribonuclease A
por: Ericksen, Bryan
Publicado: (2023)

Solving HNP with One Bit Leakage: An Asymmetric Lattice Sieving Algorithm
por: Shi, Wenhao, et al.
Publicado: (2022)

Inhibition of SARS-CoV-2 Infection by Human Defensin HNP1 and Retrocyclin RC-101
por: Kudryashova, Elena, et al.
Publicado: (2022)

Biochemical Features and Physiological Roles of hNP22 in the Central Nervous System
por: Wu, Ji, et al.
Publicado: (2021)

The Effect of Nonsurgical Periodontal Therapy on HNP1-3 Level in Gingival Crevicular Fluid of Chronic Periodontitis Patients
por: Dolińska, Ewa, et al.
Publicado: (2017)

A novel non-invasive diagnostic sampling technique for cutaneous leishmaniasis
por: Taslimi, Yasaman, et al.
Publicado: (2017)

Elevated Plasma α-Defensins (HNP1–3) Levels Correlated with IgA1 Glycosylation and Susceptibility to IgA Nephropathy
por: Qi, Yuan-yuan, et al.
Publicado: (2016)

DNA plasmid coding for Phlebotomus sergenti salivary protein PsSP9, a member of the SP15 family of proteins, protects against Leishmania tropica
por: Gholami, Elham, et al.
Publicado: (2019)

Correction: DNA plasmid coding for Phlebotomus sergenti salivary protein PsSP9, a member of the SP15 family of proteins, protects against Leishmania tropica
por: Gholami, Elham, et al.
Publicado: (2019)

Recombinant HNP-1 Produced by Escherichia coli Triggers Bacterial Apoptosis and Exhibits Antibacterial Activity against Drug-Resistant Bacteria
por: Xie, Qi, et al.
Publicado: (2022)

Isolation, characterization, and functional study of extracellular vesicles derived from Leishmania tarentolae
por: Shokouhy, Mehrdad, et al.
Publicado: (2022)

Structural analysis of PpSP15 and PsSP9 sand fly salivary proteins designed with a self-cleavable linker as a live vaccine candidate against cutaneous leishmaniasis
por: Lajevardi, Mahya Sadat, et al.
Publicado: (2022)

Tape-disc-loop-mediated isothermal amplification (TD-LAMP) method as noninvasive approach for diagnosis of cutaneous leishmaniasis caused by L. tropica
por: Taslimi, Yasaman, et al.
Publicado: (2023)

Does co-expression of Yarrowia lipolytica genes encoding Yas1p, Yas2p and Yas3p make a potential alkane-responsive biosensor in Saccharomyces cerevisiae?
por: Dabirian, Yasaman, et al.
Publicado: (2020)

β-Nitrostyrenes as Potential Anti-leishmanial Agents
por: Shafi, Syed, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hjbouve0qudl7uevvpiqhr17u7